Abstract
Four mechanisms have been proposed in the literature to explain beryllium toxicity; they can be divided in two groups of two mechanisms: (i) replacement type: models 1 and 2; (ii) addition type: models 3 and 4. At this moment is not possible to select the best model not even to establish if one of these models will be the ultimate mechanism of beryllium toxicity. However, it is important to know the still open discussion about something so important associated with one of the simplest elements of the periodic table.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Regarding the abundance of beryllium in the environment and the sources for humans, the main conclusions are the following [1,2,3,4,5,6,7,8]:
-
Beryllium is found in the earth’s crust at a concentration of 2.8 to 5.0 mg/kg. The only significant beryllium ores are beryl, which contains 4% beryllium, and bertrandite, which contains less than 1% beryllium.
-
Metallic beryllium, beryllium alloys, and beryllium oxide are derived from beryllium processing and account for 10%, 75%, and 15% of total beryllium hydroxide use, respectively. Annual beryllium air emissions from production and processing are about 8.9 tons/year, which represents 4.4% of total beryllium air emissions from all sources.
-
The main source of beryllium in the atmosphere, responsible for emissions of about 200 tons/year and 95% of all atmospheric beryllium, is the combustion of fossil fuels, especially coal. Beryllium enters water in wastewater from iron and steel as well as non-ferrous industries.
-
Soluble beryllium compounds are extremely rare in commerce, and only small amounts are occasionally used in research facilities. Other than these minimal amounts, human exposure to soluble species is restricted to extraction and concentration facilities. Approximately 20 tons/year of pure beryllium is used in certain applications, such as X-ray windows, nuclear reactors, and aerospace techniques.
-
Beryllium-containing alloys represent the largest percentage (75%) of the beryllium-containing materials market. They are used in electronic, energy, automotive, and aeronautical applications due to their high elasticity, conductivity, electrical and thermal resistance, oxidation resistance, and high melting point.
-
The toxicity of beryllium is a complex problem because beryllium has both acute and chronic toxicities and also because Be0 and Be2+ are toxic although the toxicity of Be0 seems to be due to its oxidation to Be2+ [9, 10], in the presence of protic acids. This has leaded some authors [11] to use in their papers the word beryllium for both species, a source of confusion. Studies on the toxicity of beryllium and on chronic beryllium disease, CBD, are very numerous and extend over 60 years [1, 5, 8, 12,13,14,15,16,17]. For many authors, beryllium is the most toxic non-radioactive element in the periodic table [18, 19], but Buchner does not agree having stated that “the acute toxicity of beryllium ions does not exceed that of other toxic cations like Cd2+, Ba2+, Hg2+ or As3+” [20, 21].
-
An aspect of the Be2+ properties that is very relevant for its toxicity is its tetracoordination [18, 22,23,24,25,26]. Although hexacoordinated Be2+ is a minimum in the potential surface [27, 28], tetracoordinated is much more stable to the point that [Be(H2O)6]2+ isomerizes into [Be(H2O)4]2+·2 H2O, i.e., two water molecules prefer to be placed in the second coordination sphere [29,30,31]. The small size of Be2+ is the origin of its tetracoordination [18] and to the name “tetracoordinated proton” [32]. A field of great interest is the search for molecules that can behave as chelating agents of Be2+ with the purpose to find detoxifying compounds; these compounds are generally carboxylic acids or carboxylate anions [19, 33, 34].
-
Finally we must remember the problem encountered when using X-ray crystallography: due to the low number of electrons in Be2+ (only two), its localization is not possible via protein X-ray crystallography [21, 35]. This problem is the same with hydrogen atoms (only one electron).
-
Note that a search in the Brookhaven protein data bank affords 407 structures containing Be [36], but they are all compounds containing BeF3(–), beryllium trifluoride used as a phosphate analog [37, 38]. In the structures reported in the following discussion, the Be2+ atoms are not “seen” but placed in the position that best fit with the ligands.
Discussion
Four mechanisms have been proposed to explain Be2+ toxicity:
-
Model 1: Be2+ replaces Mg2+ or Ca2+ in the protein [16, 39, 40].
-
Model 2: Be2+ replaces H+ in O···H···O ionic hydrogen bonds (HBs); on the other hand, Mg2+ is unable to do this [2, 32, 41]. This mechanism has been questioned [42].
-
Model 3: In an empty pocket of a protein enters the cluster [Be4O]6+ [43,44,45].
-
Model 4: In an empty pocket of a protein enters Be2+ and Na+ without counter anions, that is, in the X-ray structure, there are not anions such Cl– or HSO4– [46, 47]. The empty pockets of these proteins before entering Be2+ and Na+ have been found [48, 49].
These models can be classified in two types: (i) replacement type: models 1 and 2; (ii) addition type: models 3 and 4.
Model 1
According to Sukharev [40], the toxicity of Be2+ is due to the fact that it can replace Ca2+ in phosphatidylserine (Fig. 1):
Comments: (a) in these structures there are no counterions type Cl–; (b) the charges are not balanced, the missing negative ones should be in other parts of the protein; (c) the phosphate groups play a fundamental role since beryllium has more affinity for phosphates than for carboxylates. Opposed to comment b, and to facilitate possible theoretical studies, in Fig. 2, there are some neutral systems that could be used as simple models of Fig. 1 structures.
Structure A of Fig. 1 is close to that of tetra-aqua beryllium. A search in the Cambridge Structural Database (CCDC) [50] affords seven structures of [Be(H2O)4]2+ with reference codes CADZIS, CICXOC, INIMAU, KIDREU, KIDREU01, KIQPEH, and MINKUP. In Fig. 3 is represented that of CICXOC [51].
Model 2
Ionic hydrogen bonds, both cationic and anionic, are stronger than neutral HBs. They have a fundamental role on the structure of biomolecules, peptides, and proteins [52, 53]. The replacement of a proton by Be2+ (“tetrahedral proton” [32]) produces a profound distortion of the biomolecule, distortion that could explain the beryllium toxicity. This was Scott’s “new paradigm” [11, 32] also supported by McDowell [41]. According to Scott, beryllium has the potential to replace such protons and dramatically alter binding interactions that are known to illicit immune responses. It is known that [Be(H2O)4]2+ readily deprotonates to afford OH– centers. Replacing H by Be results in the reaction of Fig. 4 that may go a step further to a tetrahedral Be2+ complex.
The concept of “tetrahedral proton” [26] has been frequently cited by our group but independently of the toxicity mechanism [54,55,56,57,58,59].
Houk [52] based the protic mechanism (Fig. 5) on a series of papers by Gerlt and Gassman [60,61,62]; these authors propose a mechanism involving an ionic HB. The strong increase in acidity of the protons of the methyl group due to the coordination with BeCl2 has been observed for many other systems [57, 63].
McDowell wrote that: “It was found that the beryllium ion was energetically very effective in displacing the proton from hydrogen bonds, whereas the magnesium ion was unable to do so.” Several models were studied: Cl−···H–F, Cl¯···Be–F, Cl¯···Mg–F, H2O···H–F, H2O···Be–F+, H2O···Mg–F+ [41].
However, Buchner doubted this mechanism precisely due the high distortion [42]. According to him, “However, the substitution of the two-fold coordinated proton by a tetrahedral coordinated Be2+ ion would cause a massive decrease of the bond angle to about 109º. The bond angle in hydrogen bonds tends to be as linear as possible, and almost never below 120º. This would lead to strong changes in the conformation of the protein. It is questionable if a Be2+ species would acidify a proton of a hydroxy group enough to liberate it, forming RO–, it and to our knowledge this has not been shown.”
Model 3
This model involves “basic beryllium salts,” that is Be4O(6+)X(6–) (Fig. 6). X cannot be a chloride; it must be a bridging ligand such as acetate or nitrate; each oxygen coordinates with a different beryllium atom. Remember that two amino acids have a supplementary CO2H group, aspartic and glutamic acids (D and E) [44, 45].
This cation is formed by reaction beryllium diacetate with water:
The main conclusion of the last paper [45] is that the calculated structure (Fig. 7 right) coincides with the protein HLA-DP2β1 that contains Be and Na [48]. In this publication, the location of the Be2+ ion was not determined (“how Be-containing complexes might occupy this site”), it was situated from the surrounding O atoms.
The synthesis of Be4O6+ Ac66– (Urbain method) is represented in Fig. 8. According to the literature basic beryllium acetate (BBA) is obtained from beryllium hydroxide and acetic acid, but in the equation, beryllium acetate is used.
In reference [45], it was written “The composition of a [Be4O]6+/M2/DP2 complex (Fig. 7, right) suggests that its formation under physiological conditions should be a rather slow, rarely occurring process, since four Be2+ cations have to accumulate in the small coordination site S and also since an oxide dianion (O=) has to be formed. This very general expectation would meet the fact that CBD has long, and partially very long latency times.” Actually, the synthesis of the proposed structure in physiological conditions seems highly improbable.
Thirteen X-ray structures like those of Figs. 7 and 8 (right) have been published in the CCDC [50]: BAHLAB, BAHLEF, BAHLIJ, BAHLOR, BAHLUV, BAHQIO, BEOACT, BEOACT01, BEOACT02, BEOACT03, OCOQAY, OCOQEC, and VASFOM. We have represented in Fig. 9 those of BAHLIJ [64] and BEOACT [65].
Model 4
Model 4 is closely related to model 3: instead of a beryllium tetramer, model 4 proposes a Be2+ + two Na+ [46, 47], but the protein is the same, HLA-DP2, and the anions obviously also the same, C and E, Fig. 10 [46].
An empty pocket, the same as in model 3, accepts the Be2+ cation that rearranges about it (see black arrows). Be2+ is tetracoordinated with one aspartic and three glutamic. The structure also includes a Na+ cation at 2.74 Å of the Be2+.
A theoretical paper, QM/MM, published in 2020 [47], studied the above proposal and also the M2-peptide in the role of Be2+. They wrote, “A small and electropositive Be2+-ion accompanied by Na+-ions binds to the cavity rather strongly and induces synergistic conformational changes of the amino acid residues at the TCR (T-cell receptor protein) binding surface of the HLA-DP2_M2 complex.” Since here is only one beryllium atom, instead of four atoms of the model 3, the carboxylic residues bind using only an O atom.
Buchner wrote in 2020 [67]: “However, due to the inherent low resolution in protein X-ray crystallography a direct localization of the atoms inside the acidic pocket was not possible [46].” Therefore, computational chemistry was used to evaluate the species bound inside. This resulted in two models, which either propose the coordination of a single Be2+ ion together with one or two Na+ ions [47] or the presence of an oxygen centered [Be4O]6+ tetrahedron [43,44,45]. Some authors prefer two Na+ ions instead of only one [38].
Comparison models 3 and 4
It is possible to find a common stoichiometry for models 3 and 4:
This reaction should allow comparing the relative stabilities of both models. Note that the highly toxic beryllium oxide is an important technological compound for preparing KBe2BO3F2, the sole usable crystal for deep-UV lasers [67].
Conclusions
Currently, it is not possible to select the mechanism amongst the four possibilities; it is even possible that the true mechanism would be a different one.
In Fig. 11, we have tried to summarize the four mechanisms:
The solution to this conundrum may come from a technique that makes it possible to determine the position of beryllium cations in a protein complex. New techniques such single-particle electron cryo-microscopy (cryo-EM) could be a possibility.
Availability of data and materials
The data is available upon request to the authors.
References
Reeves AL (1977) Beryllium in the environment. Clin Toxicol 10:37–48. https://doi.org/10.3109/15563657708987958
World Health Organization (1990) International program on chemical safety. Environment Health Criteria 106. Beryllium
Agency for Toxic Substances and Disease Registry (ATSDR) Case studies in environmental medicine beryllium toxicity course: WB 1095. Original Date: 23 May 2008, Expiration Date: 23 May 2011. https://www.atsdr.cdc.gov/csem/beryllium/docs/beryllium.pdf. Accessed 12 Jan 2022
Ercal N, Gurer-Orhan H, Aykins-Burns N (2001) Toxic metals and oxidative stress part 1: mechanisms involved in metal induced oxidative damage. Curr Top Med Chem 1:529–539. https://doi.org/10.2174/1568026013394831
Bruce RM, Odin M (2001) Beryllium and beryllium compounds. Concise International Chemical Assessment Document. WHO, Geneva
Taylor TP, Ding M, Ehler DS, Foreman TM, Kaszuba JP, Sauer NN (2003) Beryllium in the Environment: A Review. J Environ Sci Health A 38:439–469. https://doi.org/10.1081/ESE-120016906
McCleskey TM, Buchner V, Field RW, Scott BL (2009) Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review. Rev Environ Health 24:75–115. https://doi.org/10.1515/REVEH.2009.24.2.75
Strupp C (2011) Beryllium Metal II. A review of the available toxicity data. Ann Occup Hyg 55:43–56. https://doi.org/10.1093/annhyg/meq073
Hashimoto K, Yoda N, Osamura Y, Iwata S (1990) Molecular orbital study on the mechanism of oxidation of a beryllium atom in acidic solution. J Am Chem Soc 112:7189–7196. https://doi.org/10.1021/ja00176a017
Thomas M, Aldridge WN (1966) The inhibition of enzymes by beryllium. Biochem J 98:94–99. https://doi.org/10.1042/bj098009
Scott BL, McCleskey TM, Chaudharyn A, Hong-Geller E, Gnanakaran S (2008) The bioinorganic chemistry and associated immunology of chronic beryllium disease. Chem Commun 2837–2847. https://doi.org/10.1039/b718746g
Bamberger CE, Botbol J, Cabrini RL (1968) Inhibition of alkaline phosphatase by beryllium and aluminium. Arch Biochem Biophys 123:195–200. https://doi.org/10.1016/0003-9861(68)90119-7
Witschi HP (1970) Effects of beryllium on deoxyribonucleic acid-synthesizing enzymes in regenerating rat liver. Biochem J 120:623–634. https://doi.org/10.1042/bj1200623
Naidu A, Nirmala J, Sastry KS (1979) Beryllium toxicity in Neurospora crassa. J Biosci 1:279–287. https://doi.org/10.1007/BF02716877
Lindenschmidt RC, Sendelbach LE, Witschi HP, Price DJ, Fleming J, Joshi JG (1986) Feritin and in vivo beryllium toxicity. Toxicol Appl Pharmacol 82:344–350. https://doi.org/10.1016/0041-008X(86)90211-5
Lewis DFV, Dobrota M, Taylor MG, Parke DV (1999) Metal toxicity in two rodent species and redox potential: evaluation of quantitative structure–activity relationships. Environm Toxicol Chem 18:2199–2204. https://doi.org/10.1002/etc.5620181012
Connnett M (2008) Fluoride action network, fluoride enhances toxicity of beryllium. https://fluoridealert.org/studies/beryllium/. Accessed 12 Jan 2022
Mederos A, Domínguez S, Chinea E, Brito F, Cecconi F (2001) Review: new advances in the coordination chemistry of the beryllium(II). J Coord Chem 53:191–222. https://doi.org/10.1080/00958970108022906
Perera LC, Raymond O, Henderson W, Brothers PJ, Plieger PG (2017) Advances in beryllium coordination chemistry. Coord Chem Rev 352:264–290. https://doi.org/10.1016/j.ccr.2017.09.009
Buchner MR (2019) Recent contributions to the coordination chemistry of beryllium. Chem Eur J 25:12018–12036. https://doi.org/10.1002/chem.201901766
Buchner MR (2020) Beryllium-associated diseases from a chemist’s point of view. Z Naturforsch 75b:405–412. https://doi.org/10.1515/znb-2020-0006
Morton-Blake DA, Russel NR (1980) Molecular-orbital treatment of complex cations of magnesium and beryllium with acetonitrile. Int J Quantum Chem 18:1405–1413. https://doi.org/10.1002/qua.560180606
Kellersohn T, Delaplane RG, Olovsson I (1994) The synergetic effect in beryllium sulfate tetrahydrate - an experimental electron-density study. Acta Crystallogr Sect B 50:316–326. https://doi.org/10.1107/S010876819400039X
Marx D, Sprik M, Parinello M (1997) Ab initio molecular dynamics of ion solvation. The case of Be2+ in water. Chem Phys Lett 273:360–366. https://doi.org/10.1016/S0009-2614(97)00618-0
Wang S (2001) Luminescence and electroluminescence of Al(III), B(III), Be(II) and Zn(II) complexes with nitrogen donors. Coord Chem Rev 215:79–98. https://doi.org/10.1016/S0010-8545(00)00403-3
Gnanakaran S, Scott B, McCleskey TM, Garcia AE (2008) Perturbation of local solvent structure by a small dication: a theoretical study on structural, vibrational, and reactive properties of beryllium ion in water. J Phys Chem B 112:2958–2963. https://doi.org/10.1021/jp076001w
Bock CW, Glusker JP (1993) Organization of water around a beryllium cation. Inorg Chem 32:1242–1250. https://doi.org/10.1021/ic00059a036
Pye CC (2009) An ab initio study of beryllium(II) hydration. J Mol Struct (Theochem) 913:210–214. https://doi.org/10.1016/j.theochem.2009.07.045
Katz AK, Glusker JP, Beebe SA, Bock CW (1996) Calcium ion coordination: a comparison with that of beryllium, magnesium, and zinc. J Am Chem Soc 118:5752–5763. https://doi.org/10.1021/ja953943i
Massa W, Dehnicke K (2007) [Be(OH2)4]Cl2 – preparation, IR spectrum, and crystal structure. Z Anorg Allg Chem 633:1366–1370. https://doi.org/10.1002/zaac.200700061
Rao JS, Dinadayalane TC, Leszczynski J, Sastry GN (2008) Comprehensive study on the solvation of mono- and divalent metal cations: Li+, Na+, K+, Be2+, Mg2+ and Ca2+. J Phys Chem A 112:12944–12953. https://doi.org/10.1021/jp8032325
McCleskey TM, Ehler DS, Keizer TS, Asthagiri DN, Pratt LR, Michalczyk R, Scott BL (2007) Beryllium displacement of H+ from strong hydrogen bonds. Angew Chem Int Ed 46:2669–2671. https://doi.org/10.1002/anie.200604623
Lindenbaum A, White MR, Schubert J (1954) Studies on the mechanism of protection by aurintricarboxylic acid in beryllium poisoning. III. Correlation of Molecular Structure with Reversal of Biologic Effects of Beryllium. Arch Biochem Biophys 52:110–132. https://doi.org/10.1016/0003-9861(54)90093-4
Sterner W, Loveless LE (1965) Screening of new chelating agents for beryllium, Aerospace Medical Research Laboratories. AMRL-TR-65–135
Chen S, Sun Z, Deng W, Li G, Liu X, Zhang Z (2022) Whole transcriptome analysis of long noncoding RNA in beryllium sulfate-treated 16HBE cells. Toxicol Appl Pharmacol 449:116097. https://doi.org/10.1016/j.taap.2022.116097
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235–242
Cho H, Wang W, Kim R, Yokota H, Damo S, Kim SH, Wemmer D, Kustu S, Yan D (2001) BeF(3)(–) acts as a phosphate analog in proteins phosphorylated on aspartate: structure of a BeF(3)(–) complex with phosphoserine phosphatase. PNAS 98:8525–8530. https://doi.org/10.1073/pnas.131213698
Schartner J, Güldenhaipt J, Mei B, Rögner M, Muhler M, Gerwert K, Kötting C (2013) Universal method for protein immobilization on chemically functionalized germanium investigated by ATR-FTIR difference spectroscopy. J Am Chem Soc 135:4079–4087. https://doi.org/10.1021/ja400253p
Aldridge WN, Thomas M (1966) The inhibition of phosphoglucomutase by beryllium. Biochem J 98:100–104. https://doi.org/10.1042/bj0980100
Ermakov YA, Kamaraju K, Dunina-Barkovskaya A, Vishnyakova KS, Yegorov YE, Anishkin A, Sukharev S (2017) High-affinity interactions of beryllium(2+) with phosphatidylserine result in a cross-linking effect reducing surface recognition of the lipid. Biochem 56:5457–5470. https://doi.org/10.1021/acs.biochem.7b00644
McDowell SAC (2009) Displacement of the proton in hydrogen bonded complexes of hydrogen fluoride by beryllium and magnesium ions. J Chem Phys 130:184312. https://doi.org/10.1063/1.3134762
Naglav D, Buchner MR, Bendt G, Kraus F, Schulz S (2016) Off the beaten track–a hitchhiker’s guide to beryllium chemistry. Angew Chem Int Ed 55:10562–10576. https://doi.org/10.1002/anie.201601809
Scott BL, Wang Z, Marrone BL, Sauer NN (2003) Potential binding modes of beryllium with the class II major histocompatibility complex HLA-DP: a combined theoretical and structural database study. J Inorg Biochem 94:5–13. https://doi.org/10.1016/S0162-0134(02)00628-1
Berger RJF, Mera-Adasme R (2016) Glutamyl-glutamate – a tailor-made chelating ligand for the [Be4O]6+ core in basic beryllium complexes and implications on investigations on the origins of chronic beryllium disease. Z Naturforsch 71b:71–75. https://doi.org/10.1515/znb-2015-0157
Berger RJF, Håkansson P, Mera-Adasme R (2020) A consistent model for the key complex in chronic beryllium disease. Z Naturforsch 75b:413–419. https://doi.org/10.1515/znb-2020-0010
Clayton GN, Wang Y, Crawford F, Novikov A, Wimberly BT, Kieft JS, Falta MT, Bowerman NA, Marrack P, Fontenot AP, Dai S (2014) Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity. Cell 158:132–142. https://doi.org/10.1016/j.cell.2014.04.048
De S, Sabu G, Zacharias M (2020) Molecular mechanism of Be2+-ion binding to HLA-DP2: tetrahedral coordination, conformational changes and multi-ion binding. Phys Chem Chem Phys 22:799–810. https://doi.org/10.1039/c9cp05695e
Dai S, Murphy GA, Crawford F, Mack DG, Falta MT, Marrack P, Kappler JW, Fontenot AP (2010) Crystal structure of HLA-DP2 and implications for chronic beryllium disease. PNAS 107:7425–7430. https://doi.org/10.1073/pnas.1001772107
Falta MT, Pinilla C, Mack DG, Tinega AN, Crawford F, Giulianotti M, Santos R, Clayton GN, Wang Y, Zhang X, Maier LA, Marrack P, Kappler JW, Fontenot AP (2013) Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease. J Exp Med 210:1403–1418. https://doi.org/10.1084/jem.20122426
Groom CR, Bruno IJ, Lightfoot MP, Ward SC (2016) The Cambridge structural database. Acta Crystallogr Sect B Struct Sci Cryst Eng Mater 72:171–179. https://doi.org/10.1107/s2052520616003954
Yashoda V, Govindarajan S, Low JN, Glidewell G (2007) Cationic, neutral and anionic metal(II) complexes derived from 4-oxo-4H-pyran-2,6-dicarboxylic acid (chelidonic acid). Acta Crystallogr Sect C 63:m207–m215. https://doi.org/10.1107/S010827010701459X
Chen J, McAllister MA, Lee JK, Houk KN (1988) Short, strong hydrogen bonds in the gas phase and in solution: theoretical exploration of pKa matching and environmental effects on the strengths of hydrogen bonds and their potential roles in enzymatic catalysis. J Org Chem 63:4611–4619. https://doi.org/10.1021/jo972262y
Meot-Ner (Mautner) M, (2005) The ionic hydrogen bond. Chem Rev 105:213–284. https://doi.org/10.1021/cr9411785
Yáñez M, Sanz P, Mó O, Alkorta I, Elguero J (2009) Beryllium bonds, do they exist? J Chem Theory Comput 5:2763–2771. https://doi.org/10.1021/ct900364y
Albrecht L, Boyd RJ, Mó O, Yáñez M (2012) Cooperativity between hydrogen bonds and beryllium bonds in (H2O)nBeX2 (n = 1–3, X = H, F) complexes. A new perspective. Phys Chem Chem Phys 14:14540–14547. https://doi.org/10.1039/c2cp42534c
Mó O, Yáñez M, Sanz P, Alkorta I, Elguero J (2012) Modulating the strength of hydrogen bonds through beryllium bonds. J Chem Theory Comput 8:2293–2300. https://doi.org/10.1021/ct300243b|
Martín-Sómer A, Montero-Campillo MM, Mó O, Yáñez M, Alkorta I, Elguero J (2014) Some interesting features of non-covalent interactions. Croat Chem Acta 87:291–306. https://doi.org/10.5562/cca2458
Brea O, Mó O, Yáñez M, Alkorta I, Elguero J (2015) Creating σ-holes through the formation of beryllium bonds. Chem Eur J 21:12676–12862. https://doi.org/10.1002/chem.201500981
Montero-Campillo MM, Lamsabhi AM, Mó O, Yáñez M (2016) Photochemical behavior of beryllium complexes with subporphyrazines and subphthalocyanines. J Phys Chem A 120:4845–4852. https://doi.org/10.1021/acs.jpca.5b12374
Gerlt JA, Gassman PG (1992) Understanding enzyme-catalyzed proton abstraction from carbon acids: details of stepwise mechanisms for β-elimination reactions. J Am Chem Soc 114:5928–5934. https://doi.org/10.1021/ja00041a004
Gerlt JA, Gassman PG (1993) An explanation for rapid enzyme-catalyzed proton abstraction from carbon acids: importance of late transition states in concerted mechanisms. J Am Chem Soc 115:11552–11568. https://doi.org/10.1021/ja00077a062
Gerlt JA, Gassman PG (1993) Understanding the rates of certain enzyme-catalyzed reactions: proton abstraction from carbon acids, acyl-transfer reactions, and displacement reactions of phosphodiesters. Biochem 32:11943–11952. https://doi.org/10.1021/bi00096a001
Montero-Campillo MM, Mó O, Alkorta I, Elguero J, Yáñez M (2022) Disrupting bonding in azoles through beryllium bonds: unexpected coordination patterns and acidity enhancement. J Chem Phys 156:194303. https://doi.org/10.1063/5.0089716
Buchner MR, Müller M (2021) Ligand influence on structural and spectroscopic properties of beryllium oxocarboxylates. Inorg Chem 60:17379–17387. https://doi.org/10.1021/acs.inorgchem.1c02939
Tulinsky A, Worthington CR, Pignataro E (1959) Basic beryllium acetate: part I. The Collection of Intensity Data. Acta Crystallogr 12:623–626. https://doi.org/10.1107/S0365110X59001852
Buchner MR (2020) Beryllium coordination chemistry and its implications on the understanding of metal induced immune responses. Chem Commun 56:8895–8907. https://doi.org/10.1039/d0cc03802d
Wu C, Jiang X, Lin L, Dan W, Lin Z, Huang Z, Humphrey MG, Zhang C (2021) Strong SHG responses in a beryllium-free deep-UV-transparent hydroxyborate via covalent bond modification. Angew Chem Int Ed 60:27151–27157. https://doi.org/10.1002/anie.202113397
Funding
Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was carried out with financial support from the Ministerio de Ciencia, Innovación y Universidades (PID2021-125207NB-C32).
Author information
Authors and Affiliations
Contributions
JE wrote the first draft of the article. IA and JE revised it.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Elguero, J., Alkorta, I. The dubious origin of beryllium toxicity. Struct Chem 34, 391–398 (2023). https://doi.org/10.1007/s11224-023-02130-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11224-023-02130-2